Wagner C - Search Results

1

Differential expression of tissue inhibitor of metalloproteinases-2 by cutaneous squamous and basal cell carcinomas.

Wagner SN, Ockenfels HM, Wagner C, Soyer HP, Goos M. Wagner SN, et al. Among authors: wagner c. J Invest Dermatol. 1996 Feb;106(2):321-6. doi: 10.1111/1523-1747.ep12342979. J Invest Dermatol. 1996. PMID: 8601735 Free article.

2

Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma.

Wagner SN, Ockenfels HM, Wagner C, Höfler H, Goos M. Wagner SN, et al. Among authors: wagner c. J Invest Dermatol. 1995 May;104(5):868-71. doi: 10.1111/1523-1747.ep12607039. J Invest Dermatol. 1995. PMID: 7738369 Free article.

3

Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy.

Wagner SN, Wagner C, Schultewolter T, Goos M. Wagner SN, et al. Among authors: wagner c. Cancer Immunol Immunother. 1997 Jun;44(4):239-47. doi: 10.1007/s002620050379. Cancer Immunol Immunother. 1997. PMID: 9222283 Free PMC article.

4

Homozygous deletion of the p16INK4a and the p15INK4b tumour suppressor genes in a subset of human sporadic cutaneous malignant melanoma.

Wagner SN, Wagner C, Briedigkeit L, Goos M. Wagner SN, et al. Among authors: wagner c. Br J Dermatol. 1998 Jan;138(1):13-21. doi: 10.1046/j.1365-2133.1998.02020.x. Br J Dermatol. 1998. PMID: 9536218

5

Predominant expression of CD44 splice variant v10 in malignant and reactive human skin lymphocytes.

Wagner SN, Wagner C, Reinhold U, Funk R, Zöller M, Goos M. Wagner SN, et al. Among authors: wagner c. J Invest Dermatol. 1998 Sep;111(3):464-71. doi: 10.1046/j.1523-1747.1998.00302.x. J Invest Dermatol. 1998. PMID: 9740242 Free article. Clinical Trial.

6

Hyaluronan-independent adhesion of CD44H+ and CD44v10+ lymphocytes to dermal microvascular endothelial cells and keratinocytes.

Weimann TK, Wagner C, Funk R, Hirche H, Goos M, Wagner SN. Weimann TK, et al. Among authors: wagner sn, wagner c. J Invest Dermatol. 2001 Oct;117(4):949-57. doi: 10.1046/j.0022-202x.2001.01467.x. J Invest Dermatol. 2001. PMID: 11676837 Free article.

7

CD44 variant isoform v10 is expressed on tumor-infiltrating lymphocytes and mediates hyaluronan-independent heterotypic cell-cell adhesion to melanoma cells.

Weimann TK, Wagner C, Goos M, Wagner SN. Weimann TK, et al. Among authors: wagner sn, wagner c. Exp Dermatol. 2003 Apr;12(2):204-12. doi: 10.1034/j.1600-0625.2003.00044.x. Exp Dermatol. 2003. PMID: 12702150

8

CpG motifs are efficient adjuvants for DNA cancer vaccines.

Schneeberger A, Wagner C, Zemann A, Lührs P, Kutil R, Goos M, Stingl G, Wagner SN. Schneeberger A, et al. Among authors: wagner sn, wagner c. J Invest Dermatol. 2004 Aug;123(2):371-9. doi: 10.1111/j.0022-202X.2004.23208.x. J Invest Dermatol. 2004. PMID: 15245438 Free article.

9

Induction of targeted cell migration by cutaneous administration of a DNA vector encoding a biologically active chemokine CCL21.

Jalili A, Pashenkov M, Kriehuber E, Wagner C, Nakano H, Stingl G, Wagner SN. Jalili A, et al. Among authors: wagner sn, wagner c. J Invest Dermatol. 2010 Jun;130(6):1611-23. doi: 10.1038/jid.2010.31. Epub 2010 Feb 25. J Invest Dermatol. 2010. PMID: 20182442 Free article.

10

Polo-like kinase 1 is a potential therapeutic target in human melanoma.

Jalili A, Moser A, Pashenkov M, Wagner C, Pathria G, Borgdorff V, Gschaider M, Stingl G, Ramaswamy S, Wagner SN. Jalili A, et al. Among authors: wagner sn, wagner c. J Invest Dermatol. 2011 Sep;131(9):1886-95. doi: 10.1038/jid.2011.136. Epub 2011 Jun 9. J Invest Dermatol. 2011. PMID: 21654832 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,239 results

Search Page

Filters